Emerging immune checkpoint inhibitors for the treatment of oropharyngeal squamous cell carcinoma

Oropharyngeal Squamous Cell Carcinoma (OPSCC) is a challenging subtype of head and neck cancer that traditionally has been associated with poor prognosis and high morbidity due to the limitations of conventional treatments such as surgery, radiation, and chemotherapy. Immune checkpoint inhibitors ha...

Full description

Bibliographic Details

Published in:	Oral Oncology Reports
Main Authors:	Pandiselvi Ravi, Shyamaladevi Babu
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Subjects:	Oropharyngeal squamous cell carcinoma Immune checkpoints Inhibitors PD-1/PDL-1 CTLA-4 Pembrolizumab and nivolumab
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906024004965